Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Immunity|July 18, 2002
CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformansCarlos P Taborda, Arturo CasadevallMethods in Molecular Biology (Clifton, N.J.)|June 7, 2017
Peptide Vaccine Against ParacoccidioidomycosisCarlos P Taborda, Luiz R TravassosHuman Vaccines & Immunotherapeutics|August 17, 2012
Paracoccidioidomycosis vaccineLuiz R Travassos, Carlos P TabordaFrontiers in Immunology|March 28, 2017
Linear Epitopes of Paracoccidioides brasiliensis and Other Fungal Agents of Human Systemic Mycoses As Vaccine CandidatesLuiz R Travassos, Carlos P TabordaEuropean Journal of Immunology|July 30, 2003
The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactionsOscar Zaragoza, Carlos P Taborda, Arturo CasadevallExpert Review of Anti-Infective Therapy|April 3, 2008
Treatment options for paracoccidioidomycosis and new strategies investigatedLuiz R Travassos, Carlos P Taborda, Arnaldo L ColomboVirulence|May 2, 2015
Dendritic cell interactions with Histoplasma and ParacoccidioidesSharanjeet K Thind, Carlos P Taborda, Joshua D NosanchukJournal of Immunology (Baltimore, Md. : 1950)|March 21, 2003
More is not necessarily better: prozone-like effects in passive immunization with IgGCarlos P Taborda, Johanna Rivera, Oscar Zaragoza, et al.Journal of Fungi (Basel, Switzerland)|July 30, 2020
Advances in Fungal Peptide VaccinesLeandro B R Da Silva, Carlos P Taborda, Joshua D NosanchukRevista Do Instituto De Medicina Tropical De Sao Paulo|October 15, 2015
PARACOCCIDIOIDOMYCOSIS: CHALLENGES IN THE DEVELOPMENT OF A VACCINE AGAINST AN ENDEMIC MYCOSIS IN THE AMERICASCarlos P Taborda, M E Urán, J D Nosanchuk, et al.Pageof 6